Literature DB >> 19275958

Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma.

Haitham Arabi1, Hui Guan, Sanjeev Kumar, Michele Cote, Sudeshna Bandyopadhyay, Christopher Bryant, Jay Shah, Fadi W Abdul-Karim, Adnan R Munkarah, Rouba Ali-Fehmi.   

Abstract

OBJECTIVE: Although microstellite instability (MSI) is a prognostic marker in colorectal cancer, it's relation with prognosis in the endometrial cancer is controversial. The goal of this study is to identify the correlation between MSI and clinicopathologic markers along with survival in high grade endometrial carcinoma EC.
METHODS: Between 1995 and 2004, we identified 119 patients (57 type-I, and 62 type-II) diagnosed with high grade EC and underwent hysterectomy. Sections were immunostained using antibodies against MLH1, MSH2, and MSH6. Semi-quantitative scoring of immunoreactivity was based on percentage of tumor staining and staining intensity. Statistical analysis and survival were assessed using the Kaplan-Meier method and Cox regression. RESULT: Tumors were considered microsatellite unstable (MSI) when at least 2/3 markers tested negative on IHC. Overall, there was no statistically significant difference in survival between patients with MSI tumors and those with microsatellite stable tumors (MSS) (p value=0.70). However, MSI tumors which tested negative for all three markers had markedly poor survival (median survival 3 months vs 71 months, p=0.04) when compared to MSS tumors. The risk of death was 13.2 times greater among women with MSI tumors (with 3 negative markers) compared to women with MSS tumors (OR=13.20 95% CI 3.50-49.76).
CONCLUSION: Although this study has its limitation due to the small sample size, it raises the question of the prognostic significance of MSI in high grade endometrial carcinoma. It also points to the importance of evaluating three mismatch repair genes (MLH1, MSH2, and MSH6) as a prognostic indicator.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275958     DOI: 10.1016/j.ygyno.2009.02.004

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Promoter hypermethylation of CIDEA, HAAO and RXFP3 associated with microsatellite instability in endometrial carcinomas.

Authors:  Yi-Wen Huang; Jingqin Luo; Yu-I Weng; David G Mutch; Paul J Goodfellow; David S Miller; Tim H-M Huang
Journal:  Gynecol Oncol       Date:  2010-03-07       Impact factor: 5.482

2.  Microsatellite instability in endometrial cancer: New purpose for an old test.

Authors:  Katherine C Kurnit; Shannon N Westin; Robert L Coleman
Journal:  Cancer       Date:  2019-03-26       Impact factor: 6.860

3.  Mismatch repair deficiency and clinicopathological characteristics in endometrial carcinoma: a systematic review and meta-analysis.

Authors:  Alaa Salah Jumaah; Hawraa Sahib Al-Haddad; Mais Muhammed Salem; Katherine Ann McAllister; Akeel Abed Yasseen
Journal:  J Pathol Transl Med       Date:  2021-04-14

Review 4.  The significance of markers in the diagnosis of endometrial cancer.

Authors:  Monika M Żyła; Jacek R Wilczyński; Marta Kostrzewa; Kinga Księżakowska-Łakoma; Marek Nowak; Grzegorz Stachowiak; Krzysztof Szyłło; Tomasz Stetkiewicz
Journal:  Prz Menopauzalny       Date:  2016-11-15

5.  Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy.

Authors:  Chuchu Zhao; Saisai Li; Menghuang Zhao; Haiyan Zhu; Xueqiong Zhu
Journal:  Arch Gynecol Obstet       Date:  2017-10-23       Impact factor: 2.344

Review 6.  The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review.

Authors:  Amelia Favier; Justine Varinot; Catherine Uzan; Alex Duval; Isabelle Brocheriou; Geoffroy Canlorbe
Journal:  Cancers (Basel)       Date:  2022-08-03       Impact factor: 6.575

7.  Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.

Authors:  Ellen Stelloo; Tjalling Bosse; Remi A Nout; Helen J MacKay; David N Church; Hans W Nijman; Alexandra Leary; Richard J Edmondson; Melanie E Powell; Emma J Crosbie; Henry C Kitchener; Linda Mileshkin; Pamela M Pollock; Vincent T Smit; Carien L Creutzberg
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.